找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Challenges in Protein Product Development; Nicholas W. Warne,Hanns-Christian Mahler Book 2018 American Association of Pharmaceutical Scien

[復(fù)制鏈接]
樓主: 實體
41#
發(fā)表于 2025-3-28 17:12:57 | 只看該作者
Analytical Characterization and Predictive Tools for Highly Concentrated Protein Formulationsion of predictive tools used during early development, specific challenges for analytical methods, and extended characterization of rheological and structural properties. The application of predictive tools during clinical lead selection and early-stage development helps to assess whether a selected
42#
發(fā)表于 2025-3-28 19:22:39 | 只看該作者
Practical Considerations for High Concentration Protein Formulationsgh concentration protein formulations have an increased tendency for high solution viscosity, physical stability sensitivities (aggregation/particulation), and non-Newtonian solution behavior (shear thinning) due to high shear rates. Process unit operations can be negatively impacted by these factor
43#
發(fā)表于 2025-3-29 02:57:00 | 只看該作者
44#
發(fā)表于 2025-3-29 03:36:05 | 只看該作者
Development of Prefilled Syringe Combination Products for Biologicsther combination products offer patients the convenience of at-home self-administration. This can result in considerable cost savings compared to dosing in a clinical setting. PFS systems improve patient compliance and dosing accuracy, reduce overfill cost and waste, and can reduce sharps injuries (
45#
發(fā)表于 2025-3-29 08:01:51 | 只看該作者
46#
發(fā)表于 2025-3-29 13:32:22 | 只看該作者
C Mini-pumpseutics in combination with particular usability needs. Introductory Sect.?. reflects on the growing requirements on drug delivery devices for biologics in connection with new indications and user groups. Section?. discusses the boundary conditions, physical basics and technical requirements. Section
47#
發(fā)表于 2025-3-29 16:15:43 | 只看該作者
Container Closure Integrity Testing of Primary Containers for Parenteral Productsntent inside. Ensuring the CCI of a parenteral product package is essential during the entire lifecycle of a product. The chapter first reviews the U.S. FDA regulatory requirements on CCI. Regulations for several regulatory authorities outside the USA are also presented for comparison. From these re
48#
發(fā)表于 2025-3-29 20:16:17 | 只看該作者
49#
發(fā)表于 2025-3-30 03:57:08 | 只看該作者
Foggingestricted to ion leaching or corrosion effects but also impacting adsorption phenomena. The formulation can creep up the walls forming a thin liquid layer on the inside of the containers. This layer is getting visible as product residues on the vial walls after a lyophilization process. This mechani
50#
發(fā)表于 2025-3-30 06:38:06 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 04:53
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
黄陵县| 额尔古纳市| 庆阳市| 泰来县| 谢通门县| 达孜县| 六安市| 来凤县| 怀来县| 常宁市| 定陶县| 什邡市| 明光市| 洞口县| 睢宁县| 邵武市| 玉屏| 噶尔县| 新邵县| 繁昌县| 东平县| 聂荣县| 浦江县| 武安市| 普格县| 铜鼓县| 抚松县| 邵武市| 林西县| 阿巴嘎旗| 隆林| 咸宁市| 土默特左旗| 普定县| 神池县| 司法| 名山县| 麻栗坡县| 来安县| 微山县| 台江县|